(Q48331742)

10 February 2018

review article

1 reference

title

Current status of antioxidant therapy for Alzheimer's Disease. (English)

1 reference

10 February 2018

0 references

Pitchumoni SS

1

1 reference

10 February 2018

Doraiswamy PM

series ordinal

2

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

10 February 2018

Journal of the American Geriatrics Society

published in

1 reference

10 February 2018

volume

46

1 reference

10 February 2018

issue

12

1 reference

10 February 2018

page(s)

1566-1572

1 reference

10 February 2018

Involvement of free radicals in dementia of the Alzheimer type: a hypothesis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Oxidative damage in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

The putative role of free radicals in the loss of neuronal functioning in senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

The Biology of Oxygen Radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Are reactive oxygen species involved in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Multiple biochemical deficits in both gray and white matter of Alzheimer brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Hippocampal membrane alteration in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Evidence for changes in the Alzheimer's disease brain cortical membrane structure mediated by cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Deprenyl suppresses the oxidant stress associated with increased dopamine turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Vitamin E protects nerve cells from amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.1998.TB01544.X

10.1111/J.1532-5415.1998.TB01544.X

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018